The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Olema Pharmaceuticals, Inc(NASDAQ:OLMA) 
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clini...
Share this website to your friends
Olema Pharmaceuticals Days Payable Outstanding ttm (DPO)
Olema Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Olema Pharmaceuticals Op Cashflow Per Share ttm
Olema Pharmaceuticals Free Cashflow Per Share ttm
Olema Pharmaceuticals Cash Per Share ttm
Olema Pharmaceuticals (GAAP) P/E ratio ttm
Olema Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.